Cancer Clinical Trial - Tesaro 4010-01-001

The Study Drug is designed to stop cancer from growing by helping your immune system recognize and fight your cancer. The Study Drug is designed to help your immune system by binding to a protein called PD-1 and stopping one of the signals that limits the ability of your immune system to recognize your cancer. This may help your immune system attack and destroy the cancer cells.

Drug

TSR-042

Trial Type

Interventional

Age Range

18 years or older

Phase

Phase 1

Condition

Endometrial Non-Small Cell Lung Cancer (NSCLC)

Keywords

Tesaro | immunotherapy | endometrial | PD-1